Which triptan for migraine relief?

November 15, 2001

N.B. Please note that if you are outside North America the embargo for Lancet Press material is 0001 hours UK time Friday 16th November 2001.

A meta-analysis of a class of drugs called the triptans-known to be effective for migraine relief -is detailed in this week's issue of THE LANCET. Three oral triptans-10 mg rizatriptan, 80 mg eletriptan, and 12.5 mg almotriptan-offer the best future chance of success.

The triptans (also known as selective serotonin 5-HT1B/1D agonists) are very effective and generally well-tolerated acute migraine drugs. Seven different oral triptans will soon be clinically available, making evidence-based selection guidelines necessary.

Michel Ferrari from Leiden University Medical Centre, The Netherlands, and colleagues pooled and analysed raw data from all the 53 available controlled clinical trials with oral triptans (12 unpublished), involving a total of over 24,000 patients. Compared with 100 mg sumatriptan, 10 mg rizatriptan showed better efficacy and consistency, and similar tolerability; 80 mg eletriptan showed better efficacy, similar consistency, but lower tolerability; 12·5 mg almotriptan showed similar efficacy after two hours of use, but scored better on the other results; 2·5 mg naratriptan and 20 mg eletriptan showed lower efficacy and (the first two) better tolerability; 2·5 mg and 5 mg zolmitriptan, 40 mg eletriptan, and 5 mg rizatriptan showed results very similar to those of 100 mg sumatriptan. The results of the 22 trials that directly compared pairs of triptans showed the same overall pattern of results.

Michel Ferrari comments: "There is an enormous body of evidence supporting the effectiveness and tolerability of the triptans in the war against migraine. Depending upon the patients' priorities, the optimal agents can be selected. In addition, when one triptan fails another drug within the class may well succeed in meeting the patients needs. Physicians thus need more than one triptan in their repertoire to best treat patients with migraine."
-end-
Contacts: Dr Michel Ferrari, Associate Professor of Neurology, Department of Neurology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; T) +31 71 526 2895; F) +31 71 524 8253; E) M.D.Ferrari@LUMC.NL

Professor Peter Goadsby, Professor of Neurology, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1 ,UK; T) +44 (0)20 7829 8749; E) peterg@ion.ucl.ac.uk

Professor Richard Lipton, Professor of Neurology, Epidemiology and Social Medicine, Albert Einstein College of Medicine, New York, NY; USA; T) +1 203 321 1050; E) rlipton@imrinc.com

Lancet

Related Migraine Articles from Brightsurf:

Disparities in migraine by sexual orientation
Survey data were used to examine the association between sexual orientation (exclusively heterosexual, mostly heterosexual, lesbian, gay or bisexual) and migraine.

Can you paint your migraine?
'Can you draw me a picture of your headache?' may sound like an unusual question - but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from surgery to alleviate migraine headaches.

Acupuncture can reduce migraine headaches
Acupuncture can reduce migraine headaches compared to both sham (placebo) acupuncture and usual care, finds a new trial from China published by The BMJ today.

Migraine rats, medical facts
Migraine mechanisms are still far from being fully understood. Escalating data from animal models are 'fact-checking' the neurophysiological and behavioral correlates of the migraine experience in humans, and how they may be affected by current anti-migraine drugs or might translate into new therapies.

Connecting the dots in the migraine brain
This dMRI study pointed to the structural strengthening of connections involving subcortical regions associated with pain processing and weakening in connections involving cortical regions associated with hyperexcitability may coexist in migraine.

Predictors of chronic migraine
A review and meta-analysis found predictors of chronic migraine. Depression, high frequency attacks, medication overuse and allodynia increased the chances for new onset chronic migraine, while annual income -- US$ 50,000 showed a protective effect.

On nitroglycerin, cardiovascular homeostasis and...bam, migraine!
Researchers in Leiden, The Netherlands, found an exaggerated cardiovascular response to nitroglycerin infusion in migraine patients, suggesting an elevated systemic sensitivity to this compound in this population.

All roads lead to migraine
Dr. Samaira Younis, from the Danish Headache Center in Copenhagen, Denmark, shares her research results, which suggests there are no differences between migraine attacks clinical characteristics following administration of 2 different compounds in patients, CGRP and sildenafil, meaning they share common cellular signaling pathways.

Running away from exercise: The curious case of migraine
In spite of the widespread recommendation for regular physical activity as a strategy to manage migraine, for some patients, exercise can instead trigger migraine attacks.

Migraine prevention in children and adolescents
Two medicines already used to prevent migraine in adults also showed efficacy in adolescents with migraine.

Read More: Migraine News and Migraine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.